| Emittent | Gattung | Typ | CUSIP/ISIN | Richtung | Bewertungsbasis | Handel | Bestand ($) | % NAV | Stück / Nennwert |
|---|---|---|---|---|---|---|---|---|---|
| Gesamt | 1.438.512.632 $ | 98,23 | 9.063.098 | ||||||
| Eli Lilly & Co. | Eli Lilly & Co. | EC | 532457108 | Long | Börsenkurs (Stufe 1) | 192.513.100 $ | 13,15 | 174.220 | |
| Johnson & Johnson | Johnson & Johnson | EC | 478160104 | Long | Börsenkurs (Stufe 1) | 123.963.722 $ | 8,46 | 550.143 | |
| UnitedHealth Group, Inc. | UnitedHealth Group, Inc. | EC | 91324P102 | Long | Börsenkurs (Stufe 1) | 101.527.558 $ | 6,93 | 266.960 | |
| AbbVie, Inc. | AbbVie, Inc. | EC | 00287Y109 | Long | Börsenkurs (Stufe 1) | 88.590.268 $ | 6,05 | 406.900 | |
| Novartis AG | Novartis AG | EC | CH0012005267 | Long | Modellwert (Stufe 2) | 75.170.633 $ | 5,13 | 499.771 | |
| Merck & Co., Inc. | Merck & Co., Inc. | EC | 58933Y105 | Long | Börsenkurs (Stufe 1) | 71.465.997 $ | 4,88 | 601.971 | |
| AstraZeneca plc | AstraZeneca plc | EC | GB0009895292 | Long | Modellwert (Stufe 2) | 68.425.768 $ | 4,67 | 368.545 | |
| Thermo Fisher Scientific, Inc. | Thermo Fisher Scientific, Inc. | EC | 883556102 | Long | Börsenkurs (Stufe 1) | 65.937.239 $ | 4,50 | 133.880 | |
| Intuitive Surgical, Inc. | Intuitive Surgical, Inc. | EC | 46120E602 | Long | Börsenkurs (Stufe 1) | 59.169.338 $ | 4,04 | 139.340 | |
| Sanofi SA | Sanofi SA | EC | FR0000120578 | Long | Modellwert (Stufe 2) | 47.371.967 $ | 3,23 | 540.411 | |
| Edwards Lifesciences Corp. | Edwards Lifesciences Corp. | EC | 28176E108 | Long | Börsenkurs (Stufe 1) | 41.055.956 $ | 2,80 | 474.800 | |
| Roche Holding AG | Roche Holding AG | EC | CH1499059983 | Long | Modellwert (Stufe 2) | 40.877.588 $ | 2,79 | 97.154 | |
| CVS Health Corp. | CVS Health Corp. | EC | 126650100 | Long | Börsenkurs (Stufe 1) | 40.058.494 $ | 2,74 | 440.300 | |
| Gilead Sciences, Inc. | Gilead Sciences, Inc. | EC | 375558103 | Long | Börsenkurs (Stufe 1) | 38.446.980 $ | 2,63 | 286.000 | |
| McKesson Corp. | McKesson Corp. | EC | 58155Q103 | Long | Börsenkurs (Stufe 1) | 31.360.666 $ | 2,14 | 42.240 | |
| Cardinal Health, Inc. | Cardinal Health, Inc. | EC | 14149Y108 | Long | Börsenkurs (Stufe 1) | 30.976.320 $ | 2,12 | 157.400 | |
| Vertex Pharmaceuticals, Inc. | Vertex Pharmaceuticals, Inc. | EC | 92532F100 | Long | Börsenkurs (Stufe 1) | 28.794.724 $ | 1,97 | 64.340 | |
| Novo Nordisk A/S | Novo Nordisk A/S, Class B | EC | DK0062498333 | Long | Modellwert (Stufe 2) | 27.872.586 $ | 1,90 | 609.968 | |
| Boston Scientific Corp. | Boston Scientific Corp. | EC | 101137107 | Long | Börsenkurs (Stufe 1) | 26.394.072 $ | 1,80 | 546.348 | |
| Bristol-Myers Squibb Co. | Bristol-Myers Squibb Co. | EC | 110122108 | Long | Börsenkurs (Stufe 1) | 25.628.076 $ | 1,75 | 448.200 | |
| Dexcom, Inc. | Dexcom, Inc. | EC | 252131107 | Long | Börsenkurs (Stufe 1) | 23.965.500 $ | 1,64 | 325.000 | |
| Hoya Corp. | Hoya Corp. | EC | JP3837800006 | Long | Modellwert (Stufe 2) | 22.213.391 $ | 1,52 | 130.800 | |
| HCA Healthcare, Inc. | HCA Healthcare, Inc. | EC | 40412C101 | Long | Börsenkurs (Stufe 1) | 17.329.561 $ | 1,18 | 45.780 | |
| Amgen, Inc. | Amgen, Inc. | EC | 031162100 | Long | Börsenkurs (Stufe 1) | 16.219.806 $ | 1,11 | 48.160 | |
| Waters Corp. | Waters Corp. | EC | 941848103 | Long | Börsenkurs (Stufe 1) | 15.066.630 $ | 1,03 | 39.280 | |
| Argenx SE | Argenx SE | EC | NL0010832176 | Long | Modellwert (Stufe 2) | 13.532.932 $ | 0,92 | 16.189 | |
| GSK plc | GSK plc | EC | GB00BN7SWP63 | Long | Modellwert (Stufe 2) | 12.871.710 $ | 0,88 | 509.032 | |
| Royalty Pharma plc | Royalty Pharma plc, Class A | EC | GB00BMVP7Y09 | Long | Börsenkurs (Stufe 1) | 12.434.480 $ | 0,85 | 223.000 | |
| Chugai Pharmaceutical Co. Ltd. | Chugai Pharmaceutical Co. Ltd. | EC | JP3519400000 | Long | Modellwert (Stufe 2) | 12.171.231 $ | 0,83 | 246.100 | |
| Regeneron Pharmaceuticals, Inc. | Regeneron Pharmaceuticals, Inc. | EC | 75886F107 | Long | Börsenkurs (Stufe 1) | 12.011.572 $ | 0,82 | 19.538 | |
| Insmed, Inc. | Insmed, Inc. | EC | 457669307 | Long | Börsenkurs (Stufe 1) | 9.611.209 $ | 0,66 | 89.900 | |
| United Therapeutics Corp. | United Therapeutics Corp. | EC | 91307C102 | Long | Börsenkurs (Stufe 1) | 8.820.029 $ | 0,60 | 15.840 | |
| Xenon Pharmaceuticals, Inc. | Xenon Pharmaceuticals, Inc. | EC | 98420N105 | Long | Börsenkurs (Stufe 1) | 7.344.766 $ | 0,50 | 134.200 | |
| Apogee Therapeutics, Inc. | Apogee Therapeutics, Inc. | EC | 03770N101 | Long | Börsenkurs (Stufe 1) | 7.228.320 $ | 0,49 | 88.000 | |
| Ascendis Pharma A/S | Ascendis Pharma A/S | EC | DK0060615755 | Long | Börsenkurs (Stufe 1) | 7.056.776 $ | 0,48 | 31.488 | |
| Rhythm Pharmaceuticals, Inc. | Rhythm Pharmaceuticals, Inc. | EC | 76243J105 | Long | Börsenkurs (Stufe 1) | 6.791.808 $ | 0,46 | 76.900 | |
| Cytokinetics, Inc. | Cytokinetics, Inc. | EC | 23282W605 | Long | Börsenkurs (Stufe 1) | 4.183.420 $ | 0,29 | 54.500 | |
| Newamsterdam Pharma Co. NV | Newamsterdam Pharma Co. NV | EC | NL00150012L7 | Long | Börsenkurs (Stufe 1) | 4.058.440 $ | 0,28 | 120.500 | |
| Gesamt | 1.438.512.632 $ | 98,23 | 9.063.098 |